CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $137,000 | -28.6% | 11,300 | -16.9% | 0.06% | -33.3% |
| Q3 2019 | $192,000 | +43.3% | 13,600 | +12.9% | 0.08% | +44.8% |
| Q2 2019 | $134,000 | +3.1% | 12,046 | +9.1% | 0.06% | +3.6% |
| Q1 2019 | $130,000 | -47.6% | 11,046 | -40.5% | 0.06% | -67.1% |
| Q4 2018 | $248,000 | -87.2% | 18,574 | -86.6% | 0.17% | -74.9% |
| Q3 2018 | $1,940,000 | -9.9% | 138,374 | +1.1% | 0.68% | -13.6% |
| Q2 2018 | $2,152,000 | -4.3% | 136,874 | +0.1% | 0.78% | +1.6% |
| Q1 2018 | $2,249,000 | -10.4% | 136,696 | -1.6% | 0.77% | -17.4% |
| Q4 2017 | $2,509,000 | -12.7% | 138,946 | -6.7% | 0.94% | -21.4% |
| Q3 2017 | $2,875,000 | +62.4% | 148,946 | -0.7% | 1.19% | +49.4% |
| Q2 2017 | $1,770,000 | +7.3% | 149,996 | -0.3% | 0.80% | -4.9% |
| Q1 2017 | $1,649,000 | +51.0% | 150,496 | +0.0% | 0.84% | +47.5% |
| Q4 2016 | $1,092,000 | – | 150,422 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |